Healthtech Startups

Rheo is developing an all-in-one device for continuous vitals-based patient monitoring, using algorithms and AI to predict patient outcomes and automate inpatient vital sign collection. It targets hospitals, serving doctors, nurses, administrators, and patients to improve care quality and reduce costs.

2 investors

Cloud-based virtual cardiac care platform aggregating data from implantable and wearable devices with AI-assisted triage.

2 investors

Ria Health provides telemedicine-based treatment for alcohol and opioid use disorders, delivered by a team of physicians, nurse practitioners, and counselors. The platform offers medication-based treatment and behavioral therapy for individuals seeking addiction recovery services.

2 investors

Ribolia (瑞博生物) is a pioneer in RNAi technology and small nucleic acid drug development, with research platforms covering drug delivery, chemical modification, and multi-target drug development. The company serves patients with chronic diseases including cardiovascular, metabolic, kidney, and liver conditions through its siRNA pipeline.

2 investors

Ricovr Healthcare develops point-of-care diagnostic technology for fast, on-site testing aimed at improving workplace safety and healthcare. The company builds medical devices in the diagnostics space.

2 investors

Rif Care is a menstrual care brand offering plant-based period products.

2 investors

Rigel is a biopharmaceutical company that develops and markets therapies including olutasidenib, pralsetinib, and fostamatinib for conditions such as acute myeloid leukemia and chronic immune thrombocytopenia. This page invites investigator-sponsored research proposals, offering study drug and/or monetary grants for independent studies aligned with Rigel's therapeutic areas.

2 investors

Rimidi provides remote patient monitoring and chronic care management software integrated with existing EHR systems, serving healthcare providers and clinicians to improve patient engagement and clinical outcomes.

2 investors

Rio Health delivers prescription medicines, personal care, baby-care, and everyday health essentials to customers' doors via WhatsApp orders, with delivery in 15–30 minutes and no minimum order or delivery fee. It operates daily from 8 AM to 1 AM, letting customers order by sending a medicine list or prescription photo.

2 investors

Rise Therapeutics develops oral immunotherapies, called Oral Immune BioModulators, using a synthetic biology-based drug design approach to treat autoimmune diseases and cancer. The company combines immunology research with in-house clinical GMP manufacturing and regulatory expertise to advance its pipeline through clinical validation.

2 investors

PromptWell offers an AI-native platform for healthcare organizations to turn routine member outreach into personalized, timely communications. It focuses on member engagement and healthcare education to help patients take an active role in their care.

2 investors

River Biomedics develops human cardiac in vitro models used for drug target and compound validation, building a pipeline of cardiac therapies. It focuses on treatments for cardiac diseases by targeting biological processes involved in their pathology.

2 investors

Rivermark Medical develops FloStent, a first-line device for treating benign prostatic hyperplasia (BPH) that is delivered during routine outpatient cystoscopy for urology practices and their patients. The device aims to restore urinary flow while preserving future treatment options.

2 investors

Rivio provides an AI-powered revenue cycle management service for hospitals, handling auditing, insurance claim submission, denial appeals, and hidden revenue recovery. It contractually guarantees full reimbursement from health insurance plans and serves the Brazilian healthcare market.

2 investors

Rivus Pharmaceuticals develops mitochondrial-targeted therapies to treat cardiometabolic diseases. The company's pipeline focuses on novel small-molecule and biologic drugs addressing metabolic dysfunction and cardiovascular health.

2 investors

RNA Diagnostics is a clinical-stage molecular diagnostics company developing a predictive biomarker platform to guide personalized cancer therapy management. The company's technology helps physicians optimize treatment decisions for cancer patients, particularly in breast cancer, to improve outcomes and reduce healthcare costs.

2 investors

Robbie provides vision AI for healthcare facilities that monitors patient environments in real-time and predicts adverse events like falls. The platform uses face and body mesh analysis to detect risks across hospitals, behavioral health facilities, skilled nursing, and home care settings without requiring wearables or video storage.

2 investors

Expper Technologies builds Robin, a research-backed therapeutic robot that provides emotional support and patient engagement in clinical settings such as pediatrics and geriatrics. It is designed to work alongside clinicians in healthcare environments including hospitals and nursing homes.

2 investors

Instem provides SaaS platforms for life sciences research organizations, covering in silico analytics, study management, regulatory submission support, and clinical trial analytics to accelerate drug and therapy development.

2 investors

roclub (Remote Operations Club) provides a cloud-based SaaS platform for remote operation of MRI and CT scanners, letting radiology staff control imaging devices and support colleagues from other locations, along with a marketplace to book external medical-technical specialists. It serves healthcare organizations in diagnostic imaging, connecting scanners from all manufacturers, with initial focus on Germany and Switzerland.

2 investors

Rosebud Biosciences develops therapies for rare genetic diseases in children by creating organoid models that replicate patient genetic mutations and using drug screening to identify potential cures. The company uses human-derived organoids combined with robotics and machine learning to accelerate drug discovery across cardiac, hepatic, neural, and kidney disease targets.

2 investors

RoseRx is a conversational AI platform for the pharmaceutical industry that converts approved content into compliant, always-on conversations with healthcare professionals and patients. It offers AI agents for information delivery, omnichannel orchestration, and embedding conversations across commercial channels such as web, email, and SMS, with pharma-grade safety and compliance controls.

2 investors

2 investors

Routes Healthcare provides home care services in the UK, including round-the-clock live-in care as an alternative to care homes, end-of-life care, and specialist support for complex clinical conditions. Its services are aimed at individuals wanting to remain living independently in their own homes, supported by trained care professionals, nurses, and managers.

2 investors